817 results on '"TISON F"'
Search Results
2. The pattern of cortical thickness associated with executive dysfunction in MCI and SCC: The MEMENTO cohort
3. French consensus procedure for assessing cognitive function in Parkinson's disease
4. Atrofia multisistemica
5. L’atrophie multisystématisée
6. Sleep Disorders in Neuroacanthocytosis
7. L‐DOPA‐induced dyskinesias, motor fluctuations and health‐related quality of life: the COPARK survey
8. Depressione e malattia di Parkinson
9. Validation of the French version of the MSA health-related Quality of Life scale (MSA-QoL)
10. New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study
11. « Drapeaux rouges » : quand s’alarmer, quel examens demander ?
12. Atrofia multisistemica
13. Prévalence et facteurs associés aux hallucinations dans la maladie de Parkinson : données préliminaires de l’étude COPARK dans la Région Midi-Pyrénées (PARKMIP)
14. Épidémiologie du syndrome des jambes sans repos
15. MÉTHODES D'ANALYSE MICROBIOLOGIQUE DES PRODUITS LAITIERS (BEURRE, FROMAGES FRAIS, YAOURTS, FROMAGES FONDUS)
16. A Phase 2 Randomized Trial of Asleep versus Awake Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease
17. A 15-year population-based cohort study of the incidence of Parkinson's disease and dementia with Lewy bodies in an elderly French cohort
18. Phenotype and genotype comparative study of typical, late onset and very late onset Friedreich ataxia: 1295
19. Freezing of gait in Parkinsonʼs disease: Prevalence, determinants and impact on quality of life: 1050
20. Clinical characteristics of long-term survivors in multiple system atrophy: An analysis of the EMSA-SG registry: 299
21. Sleep apnea syndrome is related to shorter survival and more rapid disease progression in multiple system atrophy: 283
22. Patterns of quadruple therapy use including bismuth for Helicobacter pylori eradication: A cohort study in the French national claims database
23. Cognitive and functional changes in prediagnostic phase of Parkinson disease: A population-based study
24. Evolution of postural stability after subthalamic nucleus stimulation in Parkinson’s disease: a combined clinical and posturometric study
25. Infarctus cérébraux multiples se présentant comme une dégénérescence cortico-basale : pseudo dégénérescence cortico-basale vasculaire ?
26. Atrophie multisystématisée : survie et facteurs pronostiques dans la cohorte « MSA-Aquitaine »
27. The European Multiple System Atrophy-Study Group (EMSA-SG)
28. Sleep disorders in multiple system atrophy
29. Riluzole improves motor deficits and attenuates loss of striatal neurons in a sequential double lesion rat model of striatonigral degeneration (parkinson variant of multiple system atrophy)
30. Effects of riluzole on combined MPTP + 3-nitropropionic acid-induced mild to moderate striatonigral degeneration in mice
31. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD
32. Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up
33. The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinsonʼs disease with a sexual dimorphism
34. A novel grading scale for striatonigral degeneration (multiple system atrophy)
35. Épidémiologie
36. Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinsonʼs disease: preliminary analysis from the French COPARK cohort
37. Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinsonʼs disease in the European population
38. Large-scale screening of the Gaucherʼs disease-related glucocerebrosidase gene in Europeans with Parkinsonʼs disease
39. Parkinsonʼs disease-related LRRK2 G2019S mutation results from independent mutational events in humans
40. Early results of the International Carotid Stenting Study (ICSS): safety of treatment in patients with symptomatic carotid stenosis randomised between stenting and endarterectomy: LBN 105
41. A multi-centre, placebo-controlled, double-blind trial to examine the safety and efficacy of pimavanserin in the treatment of psychosis in Parkinsonʼs disease: LBN104
42. Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson’s disease
43. Modèles animaux des syndromes parkinsoniens
44. Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls
45. Pain in multiple system atrophy
46. Side-effects of subthalamic stimulation in Parkinsonʼs disease: clinical evolution and predictive factors
47. Subthalamic nucleus stimulation in patients with Parkinsonʼs disease does not increase serum ghrelin levels
48. The restless legs syndrome
49. The G2019S LRRK2 mutation is frequent in North African families with Parkinsonʼs disease: SC315
50. Effects of pulsatile l-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.